Ignite Creation Date:
2024-05-06 @ 7:52 PM
Last Modification Date:
2024-10-26 @ 3:16 PM
Study NCT ID:
NCT06169410
Status:
RECRUITING
Last Update Posted:
2024-01-23
First Post:
2023-11-19
Brief Title:
Ramucirumab Combined With Nab-paclitaxel Lobaplatin and S-1 in Neoadjuvant Transformation Therapy for Advanced Gastric Cancer
Sponsor:
Yang Jianjun PhD
Organization:
Xijing Hospital
Organization Data
Organization:
Xijing Hospital
Class:
OTHER
Study ID:
RNPLS-01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Yang Jianjun PhD
Lead Sponsor Class:
OTHER
Responsible Party:
Yang Jianjun PhD
Responsible Party Title:
Professor from Xijing Hospital
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Xijing Hospital
Old Name:
None
Old Organization:
None